97087 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors; Serine protease (E.C. 3.4.21) inhibitors; Serpins Alpha-1-antitrypsin
COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTITRYPSIN DEFICIENCY
#2COMPOSITIONS AND METHODS FOR ALPHA-1-ANTITRYPSIN DISORDERS
#3COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME
#4METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME
#5ALPHA1-ANTITRYPSIN FOR USE IN THE TREATMENT OF DISEASES OR DISORDERS OF THE NERVOUS SYSTEM SUCH AS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
#6HIGHLY FUCOSYLATED RECOMBINANT HUMAN ALPHA 1 ANTITRYPSIN (AAT) PROTEIN HAVING IMMUNOMODULATORY ACTIVITY AND COMPOSITIONS COMPRISING THE SAME
#7COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTITRYPSIN DEFICIENCY
#8SERPIN PEPTIDES AND METHODS OF USING THE SAME
#9PLASMA FRACTIONATION UTILIZING SPRAY-DRIED HUMAN PLASMA
#10BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME
#11Lipid Nanoparticle Compositions and Methods for mRNA Delivery
#12Lipid Nanoparticle Compositions and Methods for mRNA Delivery
#13COMPOSITIONS AND METHODS OF USE FOR ALPHA-1 ANTITRYPSIN FUSION POLYPEPTIDES
#14THERAPEUTIC POLYPEPTIDE
#15Compositions and Methods for Gene Delivery to the Airways and/or Lungs
#16ALPHA-1 ANTITRYPSIN PRODUCED FROM YEAST FOR USE IN THE TREATMENT OF VIRAL INFECTIONS
#17COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROTEOPATHIES
#18SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#19VARIANTS OF ALPHA-1-ANTITRYPSIN
#20GENE EDITING METHODS FOR TREATING ALPHA-1 ANTITRYPSIN (AAT) DEFICIENCY
#21METHOD FOR OBTAINING ALPHA-1 PROTEINASE INHIBITOR
#22RAAV-BASED COMPOSITIONS AND METHODS
#23PROMOTERS
#24SIGNAL PEPTIDES
#25ALPHA-1 ANTITRYPSIN DOSING REGIMEN
#26METHODS TO GENETICALLY ENGINEER HEMATOPOIETIC STEM AND PROGENITOR CELLS FOR RED CELL SPECIFIC EXPRESSION OF THERAPEUTIC PROTEINS
#27MODIFIED SERPINS FOR THE TREATMENT OF BRADYKININ-MEDIATED DISEASE
#28METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
#29SERPINA-MODULATING COMPOSITIONS AND METHODS
#30Lipid nanoparticle compositions and methods for mRNA delivery
#31LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#32Lipid nanoparticle compositions and methods for MRNA delivery
#33Lipid nanoparticle compositions and methods for MRNA delivery
#34METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#35COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME
#36VECTORS ENCODING A GLUCOSE-6-PHOSPHATASE (G6PASE-A) FOR GENE THERAPY
#37ALPHA-1-ANTITRYPSIN MUTANTS, COMPOSITIONS COMPRISING SAME, AND USE THEREOF
#38BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME
#39Lipid nanoparticle compositions and methods for mRNA delivery
#40Optimized promoter sequences, intron-free expression constructs and methods of use
#41LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#42SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#43PROTEIN AND METABOLITE ENRICHMENT USING FOCUSED ACOUSTIC ENERGY
#44RAAV-based compositions and methods
#45Compositions and methods of use of alpha-1 antitrypsin fusion polypeptides
#46METHODS OF PRODUCING AND USING RECOMBINANT ALPHA 1-ANTITRYPSIN (AAT) AND COMPOSITIONS THEREOF
#47Lipid nanoparticle compositions and methods for mRNA delivery
#48LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#49Lipid nanoparticle compositions and methods for MRNA delivery
#50PLASMA FRACTIONATION UTILIZING SPRAY-DRIED HUMAN PLASMA
#51Lipid nanoparticle compositions and methods for mRNA delivery
#52METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#53Lipid nanoparticle compositions and methods for mRNA delivery
#54METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME
#55COMPOSITIONS AND METHODS FOR ALPHA-1-ANTITRYPSIN DISORDERS
#56Mammalian alveolar macrophages derived from pluripotent cells
#57Lipid nanoparticle compositions and methods for mRNA delivery
#58Pharmaceutical Composition Containing Fusion Protein and Use Thereof
#59Serpin peptides and methods of using the same
#60BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME
#61MODULATION OF LIVER GENES
#62Lipid nanoparticle compositions and methods for mRNA delivery
#63METHODS AND COMPOSITIONS FOR ALPHA-1 ANTITRYPSIN RELATED DISEASE DISORDERS
#64Serpin fusion polypeptides and methods of use thereof
#65Methods for extracting A1P1 and albumin from blood plasma
#66Serpin fusion polypeptides and methods of use thereof
#67COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE
#68Growth hormone receptor antagonists and fusion proteins thereof
#69RECOMBINANT MUTANT (alpha)1-ANTITRYPSIN AND PREPARATION AND USES THEREOF
#70RAAV-based compositions and methods
#71Lipid nanoparticle compositions and methods for mRNA delivery
#72VECTORS WITH PROMOTER AND ENHANCER COMBINATIONS FOR TREATING PHENYLKETONURIA
#73COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTITRYPSIN DEFICIENCY
#74COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN FUSION MOLECULES
#75METHODS AND COMPOSITIONS FOR SINGLE CHAIN VARIABLE REGION ENOX2 ANTIBODIES FOR CANCER DETECTION AND DIAGNOSIS
#76METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
#77METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#78Mutant alpha-1-antitrypsin compositions and use thereof
#79Serpin fusion polypeptides and methods of use thereof
#80Compositions and Methods of Use for Alpha-1 Antitrypsin Fusion Polypeptides
#81SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#82LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#83Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#84Methods of treatment using alpha-1-antitrypsin compositions
#85Recombinant glycoproteins with reduced antennary fucosylation
#86Peptides and methods of using same
#87Modified serpins for the treatment of bradykinin-mediated disease
#88Lipid nanoparticle compositions and methods for mRNA delivery
#89α1-antitrypsin compositions and methods of treating autoimmune diseases
#90RAAV-based compositions and methods
#91Lipid nanoparticle compositions and methods for mRNA delivery
#92Lipid nanoparticle compositions and methods for mRNA delivery
#93Method of using a transgenic mouse with alpha-one antitrypsin (ATT) deficiency to screen compounds
#94Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
#95Methods for extracting proteins from blood plasma
#96PROCESSES FOR PURIFYING PROTEINS FROM PLASMA
#97Modified serpins for the treatment of bleeding disorders
#98RAAV-BASED COMPOSITIONS AND METHODS
#99COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN FUSION MOLECULES
#100METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#101Compositions of alpha-1 antitrypsin fusion molecules
#102Methods of treatment using alpha-1-antitrypsin compositions
#103Serpin fusion polypeptides and methods of use thereof
#104PROTEIN EXPRESSION ENHANCING POLYPEPTIDES
#105Modulation of liver genes
#106Messenger UNA molecules and uses thereof
#107Compositions and methods for the diagnosis of rheumatoid arthritis
#108COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN OR DERIVATIVES THEREOF
#109RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTI-TRYPSIN DEFICIENCIES
#110Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#111Alpha-1-Antitrypsin (A1AT) Fusion Proteins and Uses Thereof
#112Mouse model of alpha-one antitrypsin (AAT) deficiency
#113Diagnosis of sepsis and systemic inflammatory response syndrome
#114COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTITRYPSIN Fc FUSION MOLECULES
#115Lipid nanoparticle compositions and methods for MRNA delivery
#116ADENO-ASSOCIATED VIRUS SEROTYPE I NUCLEIC ACID SEQUENCES, VECTORS AND HOST CELLS CONTAINING SAME
#117ALPHA1 -ANTITRYPSIN COMPOSITIONS AND METHODS OF TREATING AUTOIMMUNE DISEASES
#118Chemically inducible cucumber mosaic virus protein expression system
#119Serum-free stable transfection and production of recombinant human proteins in human cell lines
#120COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE
#121Methods of treatment using alpha-1-antitrypsin compositions
#122Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#123Methods for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#124Peptides and methods of using same
#125Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
#126Compositions and methods for preparing a subject for organ or non-organ implantation
#127Peptide and a use thereof
#128Methods and compositions for modulating alpha-1 antitrypsin expression
#129rAAV-based compositions and methods
#130Modified serpins for the treatment of bleeding disorders
#131Purification of cell culture derived alpha1 protease inhibitor
#132Serum-free stable transfection and production of recombinant human proteins in human cell lines
#133MESSENGER UNA MOLECULES AND USES THEREOF
#134Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses
#135Compositions and methods for the diagnosis of rheumatoid arthritis
#136Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same
#137Proteins with modified glycosylation and methods of production thereof
#138Methods of treatment using alpha-1-antitrypsin compositions
#139Protein expression enhancing polypeptides
#140Pharmaceutical compositions containing polypeptides derived from α-1 antitrypsin and methods of use thereof
#141Peptide for treatment of disease or symptoms associated with pain
#142COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN OR DERIVATIVES THEREOF AS RADIOPROTECTANTS
#143Serpin fusion polypeptides and methods of use thereof
#144WAP domain fusion polypeptides and methods of use thereof
#145Method of purifying a long-acting human growth hormone
#146Serpin fusion polypeptides and methods of use thereof
#147Methods and compositions for modulating alpha-1-antitrypsin expression
#148Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)
#149Serum-free stable transfection and production of recombinant human proteins in human cell lines
#150Peptides and methods of using same
#151Alpha-1 antitrypsin variant, preparation method thereof and use thereof
#152Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules
#153Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
#154Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
#155ALPHA-1-ANTITRYPSIN COMPOSITIONS
#156Ethanol dependence of alpha1 antitrypsin C-terminal Lys truncation by basic carboxypeptidases
#157Pulmonary delivery of mRNA
#158MRNA therapy for Fabry disease
#159Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#160METHODS FOR ISOLATING BLOOD PRODUCTS FROM AN INTER-ALPHA INHIBITOR PROTEIN-DEPLETED BLOOD PRODUCT MATERIAL
#161Macrocyclic cysteine protease inhibitors and compositions thereof
#162COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE
#163Methods for purification of alpha-1-antitrypsin and apolipoprotein A-1
#164Serpin-finger fusion polypeptide
#165Purification of cell culture derived alphaprotease inhibitor
#166Serpin fusion polypeptides and methods of purification thereof
#167Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses
#168Peptides and methods of using same
#169Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
#170Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same
#171WAP domain fusion polypeptides and methods of use thereof
#172Serpin fusion polypeptides and methods of use thereof
#173Method for producing proteins in that lack detectable cross binding activity to antibodies against host cell antigens
#174COMPOSITIONS, METHODS AND USES FOR TREATMENT OF TYPE 1 DIABETES
#175Recombinant human Alpha1-antitrypsin
#176Monocot seed product comprising a human blood protein
#177RECOMBINANT PROBIOTIC BACTERIA FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) AND IRRITABLE BOWEL SYNDROME (IBS)
#178Alpha-1-antitrypsin compositions and methods of use
#179In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasng in vivo half-life using same
#180Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#181Chemically inducible cucumber mosaic virus protein expression system
#182Alpha 1-antitrypsin compositions and methods of making and using same
#183Expression of factor IX in gene therapy vectors
#184METHOD OF PREPARING ALPHA-1 PROTEINASE INHIBITOR
#185Ultra-high yield of alpha-1-anti-trypsin
#186LARGE SCALE PREPARATION OF ALPHA-1 PROTEINASE INHIBITOR AND USE THEREOF
#187Methods for purification of alpha-1-antitrypsin andapolipoprotein A-1
#188Macrocyclic cysteine protease inhibitors and compositions thereof
#189COMPOSITIONS, METHODS AND USES FOR TREATING BACTERIAL INFECTIONS
#190METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
#191Alpha-1-antitrypsin compositions
#192Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions
#193ADENO-ASSOCIATED VIRUS SEROTYPE I NUCLEIC ACID SEQUENCES, VECTORS AND HOST CELLS CONTAINING SAME
#194Thermostable alpha1-antitrypsin mutein with a disulfide bond and the method for preparing it
#195Compositions, methods and uses for inhibition and/or treatment of influenza infection
#196Serum-free stable transfection and production of recombinant human proteins in human cell lines
#197Monocot seed product comprising a human serum albumin protein
#198COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING MYCOBACTERIAL INFECTIONS
#199EXPRESSION OF HUMAN MILK PROTEINS IN TRANSGENIC PLANTS
#200Alpha-1-Antitrypsin Variants and Uses Thereof
#201Human Blood Proteins Expressed in Monocot Seeds
#202Method for the purification of alpha-1-antitrypsin
#203HUMAN BLOOD PROTEINS EXPRESSED IN MONOCOT SEEDS
#204Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
#205rAAV-delivered alpha-1-antitrypsin compositions and method for the treatment and prevention of diabetes
#206Method of protein production in yeast
#207Expression of human milk proteins in transgenic plants
#208Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions
#209COMPOSITIONS AND METHODS OF USE FOR ALPHA-1 ANTITRYPSIN HAVING NO SIGNIFICANT SERINE PROTEASE INHIBITOR ACTIVITY
#210Expression of factor IX in gene therapy vectors
#211Large scale preparation of alpha-1 proteinase inhibitor and use thereof
#212Multifunctional protease inhibitors and their use in treatment of disease
#213Expression of human milk proteins in transgenic plants
#214Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same
#215Adeno-associated virus serotype I nucleic acid sequences, vectors and host cell containing same
#216Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
#217Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases
#218R-ALPHA1 antitrypsin anion exchange chromatography
#219Methods for production of recombinant alpha1-antitrypsin
#220Dry recombinant human alpha 1-antitrypsin formulation
#221Method for the purification of alpha-1 proteinase inhibitor (a1PI)
#222Erythropoietin: remodeling and glycoconjugation of erythropoietin
#223Remodeling and glycoconjugation of peptides
#224Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
#225Process for preparing an alpha-1-antitrypsin solution
#226Plant transcription factors and enhanced gene expression
#227Pharmaceutical compositions of glycoconjugates
#228Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
#229Methods of protein production in yeast